LFWD (Lifeward) Debt-to-Asset : 0.03 (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Lifeward Debt-to-Asset?

Lifeward's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.86 Mil. Lifeward's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.02 Mil. Lifeward's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was $30.49 Mil. Lifeward's debt to asset for the quarter that ended in Dec. 2024 was 0.03.

Lifeward Debt-to-Asset Historical Data

The historical data trend for Lifeward's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeward Debt-to-Asset Chart

Lifeward Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.06

0.01

0.03

Lifeward Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.02	0.03

Competitive Comparison of Lifeward's Debt-to-Asset

For the Medical Devices subindustry, Lifeward's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifeward's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeward's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Lifeward's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Lifeward Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Lifeward's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.858	+	0.022)	/	30.487
	=	0.03

Lifeward's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.858	+	0.022)	/	30.487
	=	0.03

Lifeward (NAS:LFWD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Lifeward Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Lifeward's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifeward Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeward Ltd (NAS:LFWD) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Donald Lynch Boulevard, Marlborough, MA, USA, 01752

Website

https://www.golifeward.com

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Executives

Turk Joseph E Jr	director	NXSTAGE MEDICAL INC, 439 SOUTH UNION STREET 5TH FLOOR, LAWRENCE MA 01843
Randel Richner	director	C/O REWALK ROBOTICS, LTD., 3 HATNUFA ST. 6TH FL. P.O. BOX 161, YOKNEAM L3 2069203
Lawrence J Jasinski	director, officer: Chief Executive Officer	SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
Jeannine Lynch	officer: VP of Market Access & Strategy	C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT L3 20692203
Michael A Lawless	officer: Chief Financial Officer	C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Lind Global Fund Ii Lp	10 percent owner	444 MADISON AVENUE, 41ST FLOOR, NEW YORK NY 10022
Lind Global Macro Fund Lp	10 percent owner	444 MADISON AVE, FLOOR 41, NEW YORK NY 10022
Jeff Dykan	director	KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Aryeh Dan	director	KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Charles Remsberg	officer: Chief Sales Officer	C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Poduska John William Sr	director	295 MEADOWBROOK RD, WESTON MA 02493
Yasushi Ichiki	director	KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Yohanan Engelhardt	director	3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Hadar Levy	director	C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Wayne Weisman	director	490 LAPP ROAD, MALVERN PA 19355